Saturday 24 February 2018 ,
Saturday 24 February 2018 ,
Latest News
  • Rail communications with Sylhet restored
  • 153 held over SSC question leaks: Nahid
  • 'Cyclone, violence threats loom over 700,000 Rohingya children'
  • Trump to unveil a large package of sanctions against N.Korea
  • 11 killed in road accidents across country
15 November, 2017 11:50:19 AM
Print

US approves first pill with digital tracking device

Independent Online Desk
US approves first pill with digital tracking device

US regulators have approved the first pill that contains a digital tracking sensor to alert doctors and caregivers as to whether a patient is taking a medication as scheduled.

The pill, called Abilify MyCite (aripiprazole tablets with sensor), is designed for patients with schizophrenia, bipolar disorder and depression, according to the US Food and Drug Administration.

A patient ingests the pill, and a sensor inside the pill activates when it reaches the stomach fluids, sending a message to a wearable patch.

This patch then transmits the information to a mobile app, so that a doctor and up to four caregivers, friends or family members can see the information through a web-based portal.

"Being able to track ingestion of medications prescribed for mental illness may be useful for some patients," said Mitchell Mathis, director of the division of psychiatry products in the FDA´s Center for Drug Evaluation and Research, in a statement Monday afternoon.

"The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers."

Although the sensor can alert caregivers, the makers of Abilify, Japan-based Otsuka Pharmaceutical, said it is unclear whether the tracking device will actually help improve patients´ ability to take their medication daily as prescribed.

The FDA approved Abilify in 2002 to treat schizophrenia, which affects about one percent of the US population.

The ingestible sensor used in Abilify MyCite was first allowed on the market by the FDA in 2012.

The sensor technology and patch are made by Proteus Digital Health, and are approved for use with existing medications in the United States and Europe.

But until now, the FDA had not approved a sensor-pill combination.AFP.

KK

Comments

Poll
Today's Question »
After following a nonviolent path of demonstration, do you think it will be wise on the BNP’s part to announce tougher movement for Khaleda’s release?
 Yes
 No
 No Comment
Yes 100.0%
No 0.0%
No Comment 0.0%
Video
More Health Stories
Herbal drug kratom linked to salmonella illnesses The popular botanical drug kratom is already under fire from US health officials as an addictive opioid, and now new reports are linking its use with salmonella poisoning. In a news release issued Tuesday, the US Centers for Disease…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting